Christian Möhring

发表

Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy

C. Strassburg, J. Nattermann, H. Matthaei, 2022 .

Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?

C. Strassburg, G. Feldmann, P. Brossart, 2022, Journal of Cancer Research and Clinical Oncology.

Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma

C. Strassburg, H. Matthaei, M. Gonzalez-Carmona, 2021, Cancers.

Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate

C. Strassburg, H. Matthaei, M. Essler, 2022, Frontiers in Oncology.

SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination

C. Strassburg, J. Rockstroh, C. Boesecke, 2022, Gut.

Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?

C. Strassburg, G. Feldmann, P. Brossart, 2022, Journal of Cancer Research and Clinical Oncology.

Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy

C. Strassburg, J. Nattermann, H. Matthaei, 2022, Scientific Reports.

Perioperative therapy with FLOT4 significantly increases survival in patients with gastroesophageal and gastric cancer in a large real‐world cohort

C. Strassburg, P. Brossart, M. Gonzalez-Carmona, 2023, International journal of cancer.

Impaired immunogenicity after vaccination for SARS-CoV-2 in patients with gastrointestinal cancer: does tumor entity matter?

C. Strassburg, C. Boesecke, M. Gonzalez-Carmona, 2023, Journal of gastrointestinal oncology.

First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis

C. Strassburg, G. Feldmann, H. Matthaei, 2021, Frontiers in Oncology.

Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients

C. Strassburg, J. Rockstroh, C. Boesecke, 2023, Liver Cancer.

Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy

C. Strassburg, H. Matthaei, M. Gonzalez-Carmona, 2023, Frontiers in oncology.

Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma.

H. Matthaei, J. Lasarte, P. Sarobe, 2023, Immunological investigations.

Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy

C. Strassburg, J. Nattermann, H. Matthaei, 2022, Scientific Reports.